BIO-TECHNE CORPTECH
ASignal's systematic analysis rates TECH as Neutral.
Reflects the latest available analysis · analyzed Sep 15, 2026
The case on TECH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health (debt-to-equity of 0.14x)
- High gross margin (66.24%) indicating pricing power
- Solid free cash flow generation ($229.65M)
- Current ratio of 4.55x suggests strong liquidity position
- Operating margin of 27.87% reflects efficient operations
- Low revenue growth (1.30% YoY)
- High P/E ratio (62.27x) relative to growth
- PEG ratio of 2.10x suggests overvaluation relative to growth
- No Reddit mentions, indicating low retail investor interest
- MACD below signal line, indicating weakening momentum
Peers
Clustered with TECH by analysis-profile similarity.
See the full verdict on TECH
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TECH
Most investors never get a second opinion, let alone several. ASignal runs TECH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.